Project Abstract: Polysomnographic Biomarkers of Brain Aging
Although cognitive decline is a “normal” part of aging, some individuals clearly age better than others.
However, the concept of differential aging has been minimally studied for the brain.
Electroencephalogram (EEG) oscillations signals carry rich information regarding brain health and brain aging.
Alzheimer’s disease (AD) is associated with fragmented sleep and altered sleep oscillations. Clearance of
cerebral beta amyloid through the brain's glymphatic drainage system occurs mainly in non-rapid eye
movement (NREM) sleep, and depends on EEG slow oscillations. Cortical generators of sleep EEG
oscillations overlap with regions of cortical thinning and loss of functional connectivity in AD. Disturbances of
NREM disrupt memory consolidation. Finally, deficient REM sleep contributes to dementia. These observations
suggest that brain health may be measurable from information contained in the sleep EEG.
In preliminary work we have developed EEG-brain age – a machine learning model that predicts a patient’s
age based on patterns of overnight sleeping EEG oscillations. This allows prediction of age with a precision of
+/- 7 years. Our preliminary data suggest diabetes and hypertension, chronic HIV infection, an MCI or AD are
reflected in the EEG as excessive brain age, and that excessive brain age is independently associated with
reduced life expectancy.
Our central hypothesis is that sleep physiology data can provide sensitive and specific biomarkers of brain
health. This hypothesis is based on our prior work showing that BAI is elevated in several clinical populations.
BAI can be accurately calculated using frontal EEG signals, making it suitable for implementation on at-home
EEG devices. The rationale for the proposed research is that validating sleep EEG-derived biomarkers as
measures of brain health at the level of individual patients would lay the ground for use in clinical trials and
patient care. We plan to accomplish the central objective by pursuing two complementary aims. In Aim 1, we
will take a hypothesis-driven approach, and test for associations of specific sleep features with specific
cognitive deficits and specific structural pathology. In Aim 2, we will take ad data-driven approach, and develop
optimized biomarkers of brain health using a novel form of machine learning known as multitask learning,
which combine multiple features of sleep – including conventional features, as well as data-driven features
directly learned from the data – to predict or “explain” variation in cognitive performance and in structural brain
MRI measures that are indicative of brain health or disease. The project will take advantage of a large and
diverse set of sleep data (>33,000 patients), as well as thousands of brain MRI an cognitive testing results.
At the conclusion of this study, we expect to have a better understanding of the role sleep oscillations play in
brain health, and clinically useful brain health biomarkers. These outcomes will aid development of
interventions to promote brain health.